Human resources needs for universal access to antiretroviral therapy in South Africa: a time and motion study

Table 2 Coverage indicators South Africa ^a

	Coverage indicators in South Africa
	Point estimate	Low estimate	High estimate
Receiving ART, n	971,566	NA	NA
Needing ART, n
CD4 ≤200	1,700,000	1,500,000	2,000,000
CD4 ≤350 (TB or pregnant); CD4 ≤200 (all other HIV-infected people) ^b	1,925,000	1,750,000	2,200,000
CD4 ≤350	2,600,000	2,500,000	2,800,000
CD4 ≤500^c	4,100,000	3,950,000	4,340,000
All HIV-positive people	5,600,000	5,400,000	5,900,000
Coverage,%
CD4 ≤200	56	65	48
CD4 ≤350 (TB or pregnant); CD4 ≤200 (all other HIV-infected people)^b	50	56	44
CD4 ≤350	37	39	35
CD4 ≤500^c	24	25	22
All HIV-positive people	17	18	16
Needed to initiate ART, n
CD4 ≤200	728,434	528,434	1,028,434
CD4 ≤350 (TB or pregnant); CD4 ≤200 (all other HIV-infected people)^b	952,444	778,444	1,228,444
CD4 ≤350	1,628,434	1,528,434	1,828,434
CD4 ≤500^c	3,128,434	2,978,434	3,368,434
All HIV-positive people	4,628,434	4,428,434	4,928,434

ART, antiretroviral therapy; CD4, CD4 cell count (expressed in cells/μl;); NA, not applicable.
^aSource: WHO Towards Universal Access report 2010 [23].
^bWe assumed 25% of those with CD4 cell counts of 200 to 350 μl to be eligible because of pregnancy or co-infection with tuberculosis.
^cNumber of people estimated to be between those eligible at 350 cells/μl or lower and those eligible under the strategy of ART for all HIV-infected people.

ISSN: 1478-4491